Gonadal steroids are major neuroregulators and are presumed to underlie many sex-related differences in brain structure and function. We have studied reproductive endocrine-related mood disorders as well as developed endocrine models for these disorders in order to characterize the role of gonadal steroids in affective regulation and mood disorders. Our major research findings are as follows: 1) We provide the first demonstration of an association between polymorphic genetic variants and premenstrual dysphoric disorder (PMD). Four single nucleotide polymorphisms in the estrogen receptor alpha gene positively associate with the disorder, and evidence for epistasis exists with the BDNF gene. 2) A differential reward-related pattern of brain activation in the orbital frontal cortex and the amygdala was observed in the luteal compared with the follicular phase of the menstrual cycle. 3) Administration of the Cambridge Neuropsychological Test Automated Battery and the Emotional Processing Battery to women with PMD identified impaired emotional coding and recognition, increased susceptibility to affective interference, and decreased capacity for emotional reappraisal and recovery compared with controls. 4) Application of chaos-based Approximate Entropy modeling to mood rating data yielded a suite of statistical descriptors that have very high sensitivity and specificity for PMD compared with recurrent brief depression and controls. 5) Administration of the 5 alpha reductase inhibitor, dutasteride, a medication that inhibits neurosteroid synthesis has no effect on symptoms of PMDD. 6) We have documented for the first time the hourly change in symptom ratings in women with PMDD after treatment with the selective serotonin reuptake inhibitor fluoxetine. In most women response occurs within 48 hours. These observations are of both theoretical and practical importance, as they both identify promising endophenotypes and suggest the physiological basis for the susceptibility to experience menstrual cycle-related mood disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Intramural Research (Z01)
Project #
1Z01MH002865-01
Application #
7312934
Study Section
(BEB)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2006
Total Cost
Indirect Cost
Name
U.S. National Institute of Mental Health
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Dubey, N; Hoffman, J F; Schuebel, K et al. (2017) The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder. Mol Psychiatry 22:1172-1184
Schmidt, Peter J; Martinez, Pedro E; Nieman, Lynnette K et al. (2017) Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels. Am J Psychiatry 174:980-989
Nguyen, T V; Reuter, J M; Gaikwad, N W et al. (2017) The steroid metabolome in women with premenstrual dysphoric disorder during GnRH agonist-induced ovarian suppression: effects of estradiol and progesterone addback. Transl Psychiatry 7:e1193
Kepple, Alyson L; Lee, Ellen E; Haq, Nazli et al. (2016) History of postpartum depression in a clinic-based sample of women with premenstrual dysphoric disorder. J Clin Psychiatry 77:e415-20
Harsh, Veronica; Meltzer-Brody, Samantha; Rubinow, David R et al. (2009) Reproductive aging, sex steroids, and mood disorders. Harv Rev Psychiatry 17:87-102
Huo, Liang; Straub, Richard E; Roca, Catherine et al. (2007) Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 62:925-33
Rubinow, David R; Smith, Mark J; Schenkel, Linda A et al. (2007) Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls. J Affect Disord 104:37-44
Schmidt, Peter J; Cardoso, Graca M P; Ross, Judith L et al. (2006) Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 295:1374-6
Richards, Misty; Rubinow, David R; Daly, Robert C et al. (2006) Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 163:133-7